Loading…
Based on limited metadata, this FDA Warning Letter issued to Dermameal Co., Ltd. on September 12, 2019, concerns drug products and their manufacturing or marketing practices. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, though the specific issuing office is not identified in the metadata provided. Additional details regarding the specific violations and enforcement actions would require review of the complete warning letter document.